Anaplastic lymphoma kinase (ALK) is constitutively activated due to the gene rearrangement of echinoderm microtubule‐associated protein like‐4‐ALK (EML‐4‐ALK), which is detected in 3%–5% of NSCLC patients.4 This evidence concerns the gene ALK and non-small cell lung carcinoma.